Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 3Completed 3Terminated 2Active not recruiting 2Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1CNS 1

Conditions

Neoplasms 2Motor Activity 1Hematologic Neoplasms 1Depression 1Central Nervous System Neoplasms 1

Interventions

Gemcitabine 34pembrolizumab 26Paclitaxel 21Cyclophosphamide 21Docetaxel 20Carboplatin 20Irinotecan 19Capecitabine 19Fluorouracil 17Bevacizumab 15Dexamethasone 14fludarabine 13Oxaliplatin 13Leucovorin 13Blood Specimen Collection 13Everolimus 12Cetuximab 12Ipilimumab 11Erlotinib Hydrochloride 11Rituximab 10Pemetrexed 10Cisplatin 10venetoclax 9Temozolomide 9Sunitinib 9Nivolumab 9Trastuzumab 8Interleukin-2 8aldesleukin 7Epoetin Alfa 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Neoplasms × Focus Groups × Clear all
NCT05308407 2025-08-05

POWER UP: Participating Online While Exercising to Recover Using Play

M.D. Anderson Cancer Center

Phase NA Terminated
17 enrolled
CNS

Motor Activity, Neoplasms, Central Nervous System Neoplasms

NCT05244915 2025-01-06

A Supportive Care Intervention for Older Caregivers of Older Adults with Advanced Cancer

University of Rochester

Phase NA Terminated
73 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡